In the latest trading session, 2.63 million Aadi Bioscience Inc (NASDAQ:AADI) shares changed hands as the company’s beta touched 0.67. With the company’s most recent per share price at $1.45 changed hands at -$0.17 or -10.49% at last look, the market valuation stands at $35.68M. AADI’s current price is a discount, trading about -399.31% off its 52-week high of $7.24. The share price had its 52-week low at $1.21, which suggests the last value was 16.55% up since then. When we look at Aadi Bioscience Inc’s average trading volume, we note the 10-day average is 0.15 million shares, with the 3-month average coming to 207.29K.
Analysts gave the Aadi Bioscience Inc (AADI) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.80. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended AADI as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Aadi Bioscience Inc’s EPS for the current quarter is expected to be -0.52.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aadi Bioscience Inc (NASDAQ:AADI) trade information
Instantly AADI was in red as seen in intraday trades today. With action 4.32%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -28.22%, with the 5-day performance at 4.32% in the green. However, in the 30-day time frame, Aadi Bioscience Inc (NASDAQ:AADI) is -7.64% down. Looking at the short shares, we see there were 0.19 million shares sold at short interest cover period of 1.19 days.
Aadi Bioscience Inc (AADI) estimates and forecasts
Data shows that the Aadi Bioscience Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -22.46% over the past 6 months, a 7.38% in annual growth rate that is considerably lower than the industry average of 18.50%. Year-over-year growth is forecast to reach 1.50% up from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 6.49M. 4 analysts are of the opinion that Aadi Bioscience Inc’s revenue for the current quarter will be 6.85M. The company’s revenue for the corresponding quarters a year ago was 6.61M and 6.33M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -1.80%. The estimates for the next quarter sales put growth at 8.30%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 11.87%. The 2024 estimates are for Aadi Bioscience Inc earnings to increase by 16.15%.
AADI Dividends
Aadi Bioscience Inc is expected to release its next quarterly earnings report in September.
Aadi Bioscience Inc (NASDAQ:AADI)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 10.79% of Aadi Bioscience Inc shares while 46.96% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 52.64%. There are 46.96% institutions holding the Aadi Bioscience Inc stock share, with AVORO CAPITAL ADVISORS LLC the top institutional holder. As of 2024-06-30, the company held 10.5609% of the shares, roughly 2.85 million AADI shares worth $4.16 million.
ACUTA CAPITAL PARTNERS, LLC holds the second largest percentage of outstanding shares, with 6.8545% or 1.85 million shares worth $2.7 million as of 2024-06-30.
